Ryoichi Nakanishi
Nagoya City University, Tokushima Prefectural Central Hospital
Papers
9
Total Citations
81
H-Index
5
About
Dr. Ryoichi Nakanishi is a pioneering surgeon whose work spans thoracic surgery and urologic oncology, with a focus on advancing minimally invasive techniques. His major contributions include the landmark 2023 randomized controlled trial comparing the combined use of a ProSeal laryngeal mask airway with a bronchial blocker versus a double-lumen tube in thoracoscopic surgery (32 citations), which has influenced perioperative airway management. He has also made significant strides in thymectomy for myasthenia gravis, notably examining the necessity of pericardial fat tissue resection (7 citations) and advancing the subxiphoid approach (20 citations). In urology, Dr. Nakanishi has been instrumental in evaluating robotic versus open radical cystectomy, including lymph node dissection (5 citations) and the prognostic significance of achieving the radical cystectomy-pentafecta after neoadjuvant chemotherapy (4 citations). His work on educational stepwise robot-assisted radical prostatectomy for residents (3 citations) underscores his commitment to surgical training. With over 80 total citations, Dr. Nakanishi’s research consistently seeks to improve patient outcomes through innovation and rigorous comparative studies, making him a respected figure in both thoracic and urologic surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2Thymectomy using the subxiphoid approach20 citations · 2016
- 3
- 4
- 5
- 6
- 7
- 8
- 9